US regulator approves at-home Alzheimer’s drug from Eisai and Biogen ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Leqembi
since
auto-detected in 2 stories
5 months ago
Go ahead for Leqembi shot by Food and Drug Administration could help revive two companies’ sluggish sales
12 months ago
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short ○
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
page 1 of 1